All News #Library
Sciences
PolyPid Shows Reduced SSI Severity in Phase 3 SHIELD II
28 Apr 2026 //
FIRSTWORD PHARMA
PolyPid to Participate in Oppenheimer Health Sciences Conference
30 Jan 2025 //
GLOBENEWSWIRE
PolyPid Announces R&D Collab with ImmunoGenesis for Cancer Therapy
11 Dec 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support